122 related articles for article (PubMed ID: 36335655)
1. Hypoxia regulates CD9 expression and dissemination of B lymphoblasts.
Rouger-Gaudichon J; Cousin E; Jakobczyk H; Debaize L; Rio AG; Forestier A; Arnaud MP; Villacreces A; Praloran V; Jacamo R; Galibert MD; Troadec MB; Gandemer V
Leuk Res; 2022 Dec; 123():106964. PubMed ID: 36335655
[TBL] [Abstract][Full Text] [Related]
2. CD9, a key actor in the dissemination of lymphoblastic leukemia, modulating CXCR4-mediated migration via RAC1 signaling.
Arnaud MP; Vallée A; Robert G; Bonneau J; Leroy C; Varin-Blank N; Rio AG; Troadec MB; Galibert MD; Gandemer V
Blood; 2015 Oct; 126(15):1802-12. PubMed ID: 26320102
[TBL] [Abstract][Full Text] [Related]
3. Interaction between CD9 and PI3K‑p85 activates the PI3K/AKT signaling pathway in B‑lineage acute lymphoblastic leukemia.
Shi YF; Huang ZY; Huang YS; Dong RJ; Xing CY; Yu K; Leung KT; Feng JH
Oncol Rep; 2021 Jul; 46(1):. PubMed ID: 34036396
[TBL] [Abstract][Full Text] [Related]
4. CD9 knockdown suppresses cell proliferation, adhesion, migration and invasion, while promoting apoptosis and the efficacy of chemotherapeutic drugs and imatinib in Ph+ ALL SUP‑B15 cells.
Xing C; Xu W; Shi Y; Zhou B; Wu D; Liang B; Zhou Y; Gao S; Feng J
Mol Med Rep; 2020 Oct; 22(4):2791-2800. PubMed ID: 32945456
[TBL] [Abstract][Full Text] [Related]
5. The tetraspanin CD9 regulates migration, adhesion, and homing of human cord blood CD34+ hematopoietic stem and progenitor cells.
Leung KT; Chan KY; Ng PC; Lau TK; Chiu WM; Tsang KS; Li CK; Kong CK; Li K
Blood; 2011 Feb; 117(6):1840-50. PubMed ID: 21063023
[TBL] [Abstract][Full Text] [Related]
6. CD9 regulates keratinocyte migration by negatively modulating the sheddase activity of ADAM17.
Liu J; Zhu G; Jia N; Wang W; Wang Y; Yin M; Jiang X; Huang Y; Zhang J
Int J Biol Sci; 2019; 15(2):493-506. PubMed ID: 30745837
[TBL] [Abstract][Full Text] [Related]
7. CD9 Upregulation-Decreased CCL21 Secretion in Mesenchymal Stem Cells Reduces Cancer Cell Migration.
Hsieh CC; Hsu SC; Yao M; Huang DM
Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33572290
[TBL] [Abstract][Full Text] [Related]
8. Tetraspanin CD9 links junctional adhesion molecule-A to αvβ3 integrin to mediate basic fibroblast growth factor-specific angiogenic signaling.
Peddibhotla SS; Brinkmann BF; Kummer D; Tuncay H; Nakayama M; Adams RH; Gerke V; Ebnet K
Mol Biol Cell; 2013 Apr; 24(7):933-44. PubMed ID: 23389628
[TBL] [Abstract][Full Text] [Related]
9. Hypoxia regulates CD9-mediated keratinocyte migration via the P38/MAPK pathway.
Jiang X; Guo X; Xu X; Teng M; Huang C; Zhang D; Zhang Q; Zhang J; Huang Y
Sci Rep; 2014 Sep; 4():6304. PubMed ID: 25200404
[TBL] [Abstract][Full Text] [Related]
10. The C-terminal tail of tetraspanin protein CD9 contributes to its function and molecular organization.
Wang HX; Kolesnikova TV; Denison C; Gygi SP; Hemler ME
J Cell Sci; 2011 Aug; 124(Pt 16):2702-10. PubMed ID: 21771881
[TBL] [Abstract][Full Text] [Related]
11. Downregulation of CD9 in keratinocyte contributes to cell migration via upregulation of matrix metalloproteinase-9.
Jiang XP; Zhang DX; Teng M; Zhang Q; Zhang JP; Huang YS
PLoS One; 2013; 8(10):e77806. PubMed ID: 24147081
[TBL] [Abstract][Full Text] [Related]
12. Tetraspanin CD9 affects HPV16 infection by modulating ADAM17 activity and the ERK signalling pathway.
Mikuličić S; Fritzen A; Scheffer K; Strunk J; Cabañas C; Sperrhacke M; Reiss K; Florin L
Med Microbiol Immunol; 2020 Aug; 209(4):461-471. PubMed ID: 32385608
[TBL] [Abstract][Full Text] [Related]
13. Tetraspanin CD9 stabilizes gp130 by preventing its ubiquitin-dependent lysosomal degradation to promote STAT3 activation in glioma stem cells.
Shi Y; Zhou W; Cheng L; Chen C; Huang Z; Fang X; Wu Q; He Z; Xu S; Lathia JD; Ping Y; Rich JN; Bian XW; Bao S
Cell Death Differ; 2017 Jan; 24(1):167-180. PubMed ID: 27740621
[TBL] [Abstract][Full Text] [Related]
14. Electric field down-regulates CD9 to promote keratinocytes migration through AMPK pathway.
Ji R; Teng M; Zhang Z; Wang W; Zhang Q; Lv Y; Zhang J; Jiang X
Int J Med Sci; 2020; 17(7):865-873. PubMed ID: 32308539
[TBL] [Abstract][Full Text] [Related]
15. CD9 blockade suppresses disease progression of high-risk pediatric B-cell precursor acute lymphoblastic leukemia and enhances chemosensitivity.
Leung KT; Zhang C; Chan KYY; Li K; Cheung JTK; Ng MHL; Zhang XB; Sit T; Lee WYW; Kang W; To KF; Yu JWS; Man TKF; Wang H; Tsang KS; Cheng FWT; Lam GKS; Chow TW; Leung AWK; Leung TF; Yuen PMP; Ng PC; Li CK
Leukemia; 2020 Mar; 34(3):709-720. PubMed ID: 31624373
[TBL] [Abstract][Full Text] [Related]
16. Shedding of CD9 antigen in acute lymphoblastic leukemia.
Komada Y; Sakurai M
Leuk Lymphoma; 1994 Feb; 12(5-6):365-72. PubMed ID: 8180600
[TBL] [Abstract][Full Text] [Related]
17. CD9 in acute myeloid leukemia: Prognostic role and usefulness to target leukemic stem cells.
Touzet L; Dumezy F; Roumier C; Berthon C; Bories C; Quesnel B; Preudhomme C; Boyer T
Cancer Med; 2019 Mar; 8(3):1279-1288. PubMed ID: 30740913
[TBL] [Abstract][Full Text] [Related]
18. Statins decrease lung inflammation in mice by upregulating tetraspanin CD9 in macrophages.
Jin Y; Tachibana I; Takeda Y; He P; Kang S; Suzuki M; Kuhara H; Tetsumoto S; Tsujino K; Minami T; Iwasaki T; Nakanishi K; Kohmo S; Hirata H; Takahashi R; Inoue K; Nagatomo I; Kida H; Kijima T; Ito M; Saya H; Kumanogoh A
PLoS One; 2013; 8(9):e73706. PubMed ID: 24040034
[TBL] [Abstract][Full Text] [Related]
19. CD9 regulates keratinocyte differentiation and motility by recruiting E-cadherin to the plasma membrane and activating the PI3K/Akt pathway.
Jiang X; Teng M; Ji R; Zhang D; Zhang Z; Lv Y; Zhang Q; Zhang J; Huang Y
Biochim Biophys Acta Mol Cell Res; 2020 Feb; 1867(2):118574. PubMed ID: 31682865
[TBL] [Abstract][Full Text] [Related]
20. Tetraspanin CD9 promotes the invasive phenotype of human fibrosarcoma cells via upregulation of matrix metalloproteinase-9.
Herr MJ; Kotha J; Hagedorn N; Smith B; Jennings LK
PLoS One; 2013; 8(6):e67766. PubMed ID: 23840773
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
